Table 1 2007–2013 Canadian Orphan Drug Landscape and Expenditure (2014 CAD, Millions)
Measure | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|---|---|
# “Orphan only” drugs captured N = 108 | 70 | 74 | 73 | 79 | 81 | 91 | 99 |
# “Partial Orphan” drugs captured N = 39 | 25 | 26 | 27 | 28 | 30 | 31 | 34 |
# Total Orphan drugs captured N = 147 | 95 | 100 | 100 | 107 | 111 | 122 | 133 |
“Orphan Only” Drug Expenditure ($M) | 537.6 | 586.7 | 649.2 | 692.6 | 729.3 | 786.8 | 868.0 |
“Partial Orphan” Drug Expenditure ($M) | 72.6 | 82.5 | 94.5 | 125.5 | 151.2 | 202.8 | 232.0 |
Total Orphan Drug Expenditure ($M) | 610.2 | 669.2 | 743.7 | 818.1 | 880.5 | 989.6 | 1,100.0 |
% “Orphan Only”/Total Orphan Expenditure | 88.1 % | 87.7 % | 87.3 % | 84.7 % | 82.8 % | 79.5 % | 78.9 % |
% “Partial Orphan”/Total Orphan Expenditure | 11.9 % | 12.3 % | 12.7 % | 15.3 % | 17.2 % | 20.5 % | 21.1 % |
Total Pharmaceutical Expenditure ($M) | 18,233.6 | 19,598.1 | 20,514.4 | 20,628.6 | 19,976.3 | 19,746.0 | 19,665.7 |
% Total Orphan/Total Pharmaceutical Expenditure | 3.3 % | 3.4 % | 3.6 % | 4.0 % | 4.4 % | 5.0 % | 5.6 % |